Literature DB >> 29569622

Global epidemiology of hyperthyroidism and hypothyroidism.

Peter N Taylor1, Diana Albrecht2, Anna Scholz1, Gala Gutierrez-Buey3, John H Lazarus1, Colin M Dayan1, Onyebuchi E Okosieme1.   

Abstract

Thyroid hormones are essential for growth, neuronal development, reproduction and regulation of energy metabolism. Hypothyroidism and hyperthyroidism are common conditions with potentially devastating health consequences that affect all populations worldwide. Iodine nutrition is a key determinant of thyroid disease risk; however, other factors, such as ageing, smoking status, genetic susceptibility, ethnicity, endocrine disruptors and the advent of novel therapeutics, including immune checkpoint inhibitors, also influence thyroid disease epidemiology. In the developed world, the prevalence of undiagnosed thyroid disease is likely falling owing to widespread thyroid function testing and relatively low thresholds for treatment initiation. However, continued vigilance against iodine deficiency remains essential in developed countries, particularly in Europe. In this report, we review the global incidence and prevalence of hyperthyroidism and hypothyroidism, highlighting geographical differences and the effect of environmental factors, such as iodine supplementation, on these data. We also highlight the pressing need for detailed epidemiological surveys of thyroid dysfunction and iodine status in developing countries.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29569622     DOI: 10.1038/nrendo.2018.18

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  190 in total

1.  Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism.

Authors:  G Das; T A Ojewuyi; P Baglioni; J Geen; L D Premawardhana; O E Okosieme
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

2.  Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.

Authors:  David J Stott; Nicolas Rodondi; Patricia M Kearney; Ian Ford; Rudi G J Westendorp; Simon P Mooijaart; Naveed Sattar; Carole E Aubert; Drahomir Aujesky; Douglas C Bauer; Christine Baumgartner; Manuel R Blum; John P Browne; Stephen Byrne; Tinh-Hai Collet; Olaf M Dekkers; Wendy P J den Elzen; Robert S Du Puy; Graham Ellis; Martin Feller; Carmen Floriani; Kirsty Hendry; Caroline Hurley; J Wouter Jukema; Sharon Kean; Maria Kelly; Danielle Krebs; Peter Langhorne; Gemma McCarthy; Vera McCarthy; Alex McConnachie; Mairi McDade; Martina Messow; Annemarie O'Flynn; David O'Riordan; Rosalinde K E Poortvliet; Terence J Quinn; Audrey Russell; Carol Sinnott; Jan W A Smit; H Anette Van Dorland; Kieran A Walsh; Elaine K Walsh; Torquil Watt; Robbie Wilson; Jacobijn Gussekloo
Journal:  N Engl J Med       Date:  2017-04-03       Impact factor: 91.245

3.  An increase in thyrotoxicosis in southern Tasmania after an increase in dietary iodine.

Authors:  R J Connolly
Journal:  Med J Aust       Date:  1971-06-12       Impact factor: 7.738

Review 4.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

5.  A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations.

Authors:  Ulla T Schultheiss; Alexander Teumer; Marco Medici; Yong Li; Natalie Daya; Layal Chaker; Georg Homuth; Andre G Uitterlinden; Matthias Nauck; Albert Hofman; Elizabeth Selvin; Henry Völzke; Robin P Peeters; Anna Köttgen
Journal:  J Clin Endocrinol Metab       Date:  2015-02-26       Impact factor: 5.958

6.  Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Ruth M Belin; Brad C Astor; Neil R Powe; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

7.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

8.  Increased incidence of thyrotoxicosis in Malmö during the years 1988-1990 as compared to the years 1970-1974.

Authors:  J Berglund; U B Ericsson; B Hallengren
Journal:  J Intern Med       Date:  1996-01       Impact factor: 8.989

9.  Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters.

Authors:  Kanji Kasagi; Norihiro Takahashi; Gen Inoue; Toyohiko Honda; Yasunori Kawachi; Yoichiro Izumi
Journal:  Thyroid       Date:  2009-09       Impact factor: 6.568

10.  The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I.R. Iran.

Authors:  H Delshad; L Mehran; M Tohidi; M Assadi; F Azizi
Journal:  J Endocrinol Invest       Date:  2011-09-30       Impact factor: 5.467

View more
  182 in total

Review 1.  Diagnosis and treatment of hypothyroidism in the elderly.

Authors:  Leonidas H Duntas; Paul Michael Yen
Journal:  Endocrine       Date:  2019-09-03       Impact factor: 3.633

Review 2.  Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?

Authors:  Marco Castellana; Carlo Castellana; Luca Giovanella; Pierpaolo Trimboli
Journal:  Endocrine       Date:  2020-01-17       Impact factor: 3.633

3.  Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?

Authors:  Tommaso Porcelli; Domenico Salvatore
Journal:  Endocrine       Date:  2020-06-22       Impact factor: 3.633

4.  Imbalanced testicular metabolism induced by thyroid disorders: New evidences from quantitative proteome.

Authors:  Samantha Nascimento Gomes; Deborah Elzita do Carmo Corrêa; Isabela Medeiros de Oliveira; Paula Bargi-Souza; Monica Degraf Cavallin; Danielle Dobner Mariano; Najeh Maissar Khalil; David Livingstone Alves Figueiredo; Marco Aurelio Romano; Claudio Alvarenga de Oliveira; Renata Marino Romano
Journal:  Endocrine       Date:  2019-06-29       Impact factor: 3.633

5.  Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Authors:  Susanna C Larsson; Elias Allara; Amy M Mason; Karl Michaëlsson; Stephen Burgess
Journal:  Circ Genom Precis Med       Date:  2019-03

6.  Prevalence of Components of Metabolic Syndrome Among Adults with the Presence of Autoimmune Thyroid Condition in an Iodine-Sufficient Region.

Authors:  Binyu Pan; Qin Zhang; Hang Zhou; Zheng Feei Ma
Journal:  Biol Trace Elem Res       Date:  2020-10-02       Impact factor: 3.738

7.  Effectiveness of increased salt iodine concentration on iodine status: trend analysis of cross-sectional national studies in Switzerland.

Authors:  Maria Andersson; Sandra Hunziker; Ralph Fingerhut; Michael B Zimmermann; Isabelle Herter-Aeberli
Journal:  Eur J Nutr       Date:  2019-03-01       Impact factor: 5.614

Review 8.  New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

Authors:  Peter N Taylor; Lei Zhang; George J Kahaly; Marian Ludgate; Richard W J Lee; Ilaria Muller; Daniel G Ezra; Colin M Dayan
Journal:  Nat Rev Endocrinol       Date:  2019-12-30       Impact factor: 43.330

9.  A Role of Endogenous Histone Acetyltransferase Steroid Hormone Receptor Coactivator 3 in Thyroid Hormone Signaling During Xenopus Intestinal Metamorphosis.

Authors:  Yuta Tanizaki; Lingyu Bao; Bingyin Shi; Yun-Bo Shi
Journal:  Thyroid       Date:  2020-11-20       Impact factor: 6.568

10.  The effect of hypothyroidism on referential background metabolic activity on 18F-FDG PET/CT.

Authors:  Pei Yang; Qiuping Fan; Huawei Cai; Rong Tian; Minggang Su
Journal:  Quant Imaging Med Surg       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.